Understandably, there is considerable excitement around the field of data science particularly in relation to healthcare and clinical trials. As described in another article in this newsletter “Machine Learning”, a key area of data science, is rapidly gaining traction in the healthcare industry.
At PHASTAR, the demand for data science led services has been increasing over the past few years, with many of our customers asking us to help them as they explore artificial intelligence, machine learning, and complex analytics. Data science is a multi-disciplinary field, bringing together different computational and mathematical/statistical skills with a wealth of experience in clinical trials and healthcare. There is considerable overlap between the field of data science and statistics and here at PHASTAR we have a strong and successful reputation for our statistical expertise.
PHASTAR is delighted to announce their sponsorship of the 2019 PSI Conference, taking place from 2nd – 5th June at the QEII Centre, London. We are a Queen’s-award winning, global CRO, offering statistical consulting, clinical trial reporting, data management and data science services. PHASTAR’s team will be set up at Stand 13, so be sure to stop by.
Focusing on the ‘Data Driven Decision Making in Medical Research’, this year’s conference will consist of a variety of plenary and parallel sessions on this theme, as well as breakout discussion sessions, workshops, a poster session and the Annual General Meeting. Members of PHASTAR’s senior staff will be giving presentations - look out for further updates!
It’s been almost six months since PHASTAR opened the doors to its ninth office, based in Boston! The opening represented an important milestone in PHASTAR's history as its second office in the US and its first in the important Life Science Corridor of Massachusetts.
In that time, the office has grown to include a mixture of statisticians and programmers delivering PHASTAR’s award winning services to our ever-expanding US customer base, under the guidance of Director of Biostatistics Paul Stark.
To celebrate our time in Boston thus far, PHASTAR is hosting a networking and discussion evening in the Royal Sonesta Hotel, Cambridge, MA on Thursday 13th June from 6.30pm – 9.30pm. PHASTAR will be hosting talks from a leading pharma company, a joint RWE/CDM discussion as well as a talk from a global biotechnology company. The evening promises to be a celebration of all things life science!
All are welcome to come join us – pre booking is essential and tickets are available here https://bit.ly/2L17xzj
If you are interested in learning more, please contact our Business Development Team at This email address is being protected from spambots. You need JavaScript enabled to view it.!
PHASTAR is delighted to be heading back to the far east, to exhibit at this years’ DIA Asia International Conference in Tokyo, Japan!
Exhibiting at stand I, PHASTAR’s Managing Director Andrew MacGarvey and Business Development Manager Edward Clark will be on hand over the two-day event to discuss PHASTAR’s award winning statistical consulting, clinical trial reporting and data management services. Running from 18th to 19th April, DIA Asia brings together some of the world’s most prominent figures in clinical development, medical affairs and CROs, to name a few.
Having made several trips to Japan in the past year including exhibiting at BIO Japan 2018 and a successful industry trip with JETRO this past February, PHASTAR is eager to increase its presence in Asia, which is fast becoming one of the worlds most important emerging regions in terms of drug development.
PHASTAR, the Cambridge based global CRO offering statistical consulting, clinical trial reporting and data management services is delighted to announce their sponsorship of the 2019 MassBio Annual Meeting, taking place on 27th – 28th at Royal Sonesta, Cambridge.
Focusing on the ‘State of Possible’, this year’s conference celebrates the advancements within the pharma and biotech industries and the possibilities these advancements offer the patients of today.
The MassBio conference attracts over 600 local and international pharma and biotech leaders, who over two days will discuss the challenges facing the life science industry and how to mitigate these.
